期刊
SCIENCE ADVANCES
卷 6, 期 34, 页码 -出版社
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.abb9853
关键词
-
资金
- Canadian Institutes of Health Research grant [PJT166153]
- NIH [1R01AI098546, P51OD011104, U42OD010568, U42OD024282]
Intravenous administration of anti-alpha(4)beta(7) monoclonal antibody in macaques decreases simian immunodeficiency virus (SIV) vaginal infection and reduces gut SIV loads. Because of potential side effects of systemic administration, a prophylactic strategy based on mucosal administration of anti-alpha(4)beta(7) antibody may be safer and more effective. With this in mind, we developed a novel intravaginal formulation consisting of anti-alpha(4)beta(7) monoclonal antibody-conjugated nanoparticles (NPs) loaded in a 1% hydroxyethylcellulose (HEC) gel (NP-alpha(4)beta(7) gel). When intravaginally administered as a single dose in a rhesus macaque model, the formulation preferentially bound to CD4(+) or CD3(+) T cells expressing high levels of alpha(4)beta(7), and occupied similar to 40% of alpha(4)beta(7)expressed by these subsets and similar to 25% of all cells expressing alpha(4)beta(7). Blocking of the alpha(4)beta(7) was restricted to the vaginal tract without any changes detected systemically.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据